Nature Reviews Genetics

Contents

Nature Reviews Genetics

Nature Reviews Genetics is a monthly peer-reviewed review journal published by Springer Nature that synthesizes advances across genetics, molecular biology, genomics, evolutionary biology, developmental biology, and biotechnology. The journal curates commissioned review articles, perspectives, commentaries and primers that connect discoveries from laboratories such as Broad Institute, Wellcome Sanger Institute, Cold Spring Harbor Laboratory, Max Planck Institute for Molecular Genetics, and Francis Crick Institute with policy discussions involving organizations like the European Research Council and funding bodies such as the National Institutes of Health. Authors and editorial board members have included researchers affiliated with institutions like Harvard University, University of Cambridge, Stanford University, Massachusetts Institute of Technology, and University of California, San Francisco.

History

Launched in 2000 by Nature Publishing Group as part of a series that included titles like Nature Reviews Cancer and Nature Reviews Neuroscience, the journal emerged amid a growth in large-scale projects exemplified by the Human Genome Project, the International HapMap Project, and the rise of next-generation sequencing at companies such as Illumina and Roche Diagnostics. Early issues highlighted thematic syntheses of work from consortia and centers including the 1000 Genomes Project, the ENCODE Project, and the Cancer Genome Atlas while featuring contributions from leaders who had roles at Cold Spring Harbor Laboratory and the European Molecular Biology Laboratory. Over time the journal adapted to methodological shifts such as the adoption of CRISPR-Cas9 genome editing, single-cell technologies pioneered in labs like Broad Institute, and population-scale sequencing initiatives coordinated by institutions including Wellcome Sanger Institute.

The journal covers review topics spanning human genetics, model organism genetics, population genomics, functional genomics, epigenetics, translational genetics, and computational approaches. Articles synthesize findings from landmark studies such as those published by teams at National Human Genome Research Institute, Broad Institute, and Wellcome Sanger Institute and discuss tools and platforms including pipelines developed at European Bioinformatics Institute and algorithms arising from groups at Massachusetts Institute of Technology. Content types include commissioned Reviews, which often integrate results from projects like the 1000 Genomes Project and the ENCODE Project; Primers that summarize methodologies used in laboratories such as Cold Spring Harbor Laboratory and Max Planck Institute; and Perspectives that address translational pathways involving regulatory bodies like the Food and Drug Administration or funding agencies such as the Wellcome Trust.

The editorial model is staff-led with an in-house editorial team housed at Springer Nature headquarters and supported by an international advisory board composed of researchers affiliated with Harvard University, University of Oxford, Stanford University, University College London, and ETH Zurich. Commissioning policies prioritize collective syntheses over primary research reporting, and peer review is undertaken by experts drawn from institutions including Broad Institute, Wellcome Sanger Institute, Max Planck Society, and Cold Spring Harbor Laboratory. Editorial policies emphasize declaration of competing interests in accordance with standards promoted by organizations like the Committee on Publication Ethics and follow guidelines related to data availability and reproducibility advocated by bodies such as the Wellcome Trust and the National Institutes of Health.

The journal is indexed in major bibliographic databases and citation services used by bibliometric analyses at organizations such as Clarivate, Scopus (Elsevier), and PubMed (National Library of Medicine). Abstracting services that include the journal are used by institutions and consortia like the Canadian Institutes of Health Research, the European Molecular Biology Laboratory, and university libraries at Harvard University and University of Cambridge to curate literature. Inclusion in citation indices maintained by Clarivate supports calculation of metrics that inform assessments by funding agencies such as the European Research Council and national research evaluation exercises like the Research Excellence Framework.

The journal has been recognized for high citation metrics and influence in shaping syntheses used by researchers at Broad Institute, clinicians at Mayo Clinic, and policymakers at organizations such as the World Health Organization. Its reviews are frequently cited alongside primary studies from consortia like the Cancer Genome Atlas and the 1000 Genomes Project, and are used in teaching and training at universities including University of California, San Francisco, University of Cambridge, and Stanford University. Critiques have sometimes focused on the selective commissioning model and discussions have involved debate among scholars at meetings hosted by institutions like the Royal Society and Cold Spring Harbor Laboratory about balance between invited synthesis and open submission.

Category:Academic journals Category:Genetics journals